199 related articles for article (PubMed ID: 24307729)
1. Cognate peptide-MHC complexes are expressed as tightly apposed nanoclusters in virus-infected cells to allow TCR crosslinking.
Ferez M; Castro M; Alarcon B; van Santen HM
J Immunol; 2014 Jan; 192(1):52-8. PubMed ID: 24307729
[TBL] [Abstract][Full Text] [Related]
2. T-cell receptor-mediated signal transduction in transformed human T-cells.
Arimilli S; Nag B
Recept Signal Transduct; 1997; 7(3):151-63. PubMed ID: 9440502
[TBL] [Abstract][Full Text] [Related]
3. Molecular components of T-cell recognition.
Jorgensen JL; Reay PA; Ehrich EW; Davis MM
Annu Rev Immunol; 1992; 10():835-73. PubMed ID: 1591005
[TBL] [Abstract][Full Text] [Related]
4. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
5. TCR-mediated adhesion of T cell hybridomas to planar bilayers containing purified MHC class II/peptide complexes and receptor shedding during detachment.
Dustin ML; Miller JM; Ranganath S; Vignali DA; Viner NJ; Nelson CA; Unanue ER
J Immunol; 1996 Sep; 157(5):2014-21. PubMed ID: 8757322
[TBL] [Abstract][Full Text] [Related]
6. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
Stone JD; Stern LJ
J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
[TBL] [Abstract][Full Text] [Related]
7. Fate of intercellular MHC-peptide-T-cell receptor complexes during T-cell activation.
Clark BR
J Mol Recognit; 1995; 8(1-2):63-6. PubMed ID: 7598954
[TBL] [Abstract][Full Text] [Related]
8. Serial triggering of many T-cell receptors by a few peptide-MHC complexes.
Valitutti S; Müller S; Cella M; Padovan E; Lanzavecchia A
Nature; 1995 May; 375(6527):148-51. PubMed ID: 7753171
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
11. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
[TBL] [Abstract][Full Text] [Related]
12. Modulation of T cell function by TCR/pMHC binding kinetics.
Carreño LJ; González PA; Kalergis AM
Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
[TBL] [Abstract][Full Text] [Related]
13. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.
Almagro JC; Vargas-Madrazo E; Lara-Ochoa F; Horjales E
Protein Sci; 1995 Sep; 4(9):1708-17. PubMed ID: 8528069
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors.
O'Herrin SM; Lebowitz MS; Bieler JG; al-Ramadi BK; Utz U; Bothwell AL; Schneck JP
J Exp Med; 1997 Oct; 186(8):1333-45. PubMed ID: 9334373
[TBL] [Abstract][Full Text] [Related]
16. T lymphocytes need less than 3 min to discriminate between peptide MHCs with similar TCR-binding parameters.
Brodovitch A; Shenderov E; Cerundolo V; Bongrand P; Pierres A; van der Merwe PA
Eur J Immunol; 2015 Jun; 45(6):1635-42. PubMed ID: 25782169
[TBL] [Abstract][Full Text] [Related]
17. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1.
Magarian-Blander J; Ciborowski P; Hsia S; Watkins SC; Finn OJ
J Immunol; 1998 Apr; 160(7):3111-20. PubMed ID: 9531265
[TBL] [Abstract][Full Text] [Related]
18. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
19. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
20. Idiotypic T cells specific for Morbillivirus nucleocapsid protein process and present their TCR to cognate anti-idiotypic CD8+ T cells.
Lal G; Shaila MS; Nayak R
Immunol Lett; 2006 Feb; 102(2):132-40. PubMed ID: 16188324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
